Press Releases Press Releases Year: - Any -2018201720162015201420132012201120102009 Items per page 102550 Date Title 01/09/12 Summary ToggleAkebia Draws Down $4.1 Million Series B Financing Tranche 11/21/11 Summary ToggleAkebia Initiates Phase 1 Study of First-In-Class HPTPβ Inhibitor for Diabetic Macular Edema 11/15/11 Summary ToggleAkebia Therapeutics Announces Presentation of Clinical Data at Kidney Week 2011 06/23/11 Summary ToggleAkebia Announces Initiation of Phase 2a Dose Range Finding Study of AKB-6548 for Anemia 05/03/11 Summary ToggleAkebia Announces Successful Completion of Phase 2a Pilot Study of AKB-6548 For Anemia 04/26/11 Summary ToggleAkebia Completes $22M Series B Financing 10/05/10 Summary ToggleAkebia Announces Positive Results for AKB-6548 Phase 2a Clinical Study 07/22/10 Summary ToggleAkebia Announces Initiation of Phase 2a Clinical Study of AKB-6548 06/16/10 Summary ToggleAkebia Announces Positive Results for AKB-6548 Phase 1b Clinical Study and Completes $5M Second Tranche Series A Financing 04/06/10 Summary ToggleAkebia to Participate in the Future Leaders in the Biotech Industry Conference Pagination First page First Previous page Previous … Page 11 Page 12 Current page 13 Page 14 Next page Next Last page Last
Press Releases Year: - Any -2018201720162015201420132012201120102009 Items per page 102550 Date Title 01/09/12 Summary ToggleAkebia Draws Down $4.1 Million Series B Financing Tranche 11/21/11 Summary ToggleAkebia Initiates Phase 1 Study of First-In-Class HPTPβ Inhibitor for Diabetic Macular Edema 11/15/11 Summary ToggleAkebia Therapeutics Announces Presentation of Clinical Data at Kidney Week 2011 06/23/11 Summary ToggleAkebia Announces Initiation of Phase 2a Dose Range Finding Study of AKB-6548 for Anemia 05/03/11 Summary ToggleAkebia Announces Successful Completion of Phase 2a Pilot Study of AKB-6548 For Anemia 04/26/11 Summary ToggleAkebia Completes $22M Series B Financing 10/05/10 Summary ToggleAkebia Announces Positive Results for AKB-6548 Phase 2a Clinical Study 07/22/10 Summary ToggleAkebia Announces Initiation of Phase 2a Clinical Study of AKB-6548 06/16/10 Summary ToggleAkebia Announces Positive Results for AKB-6548 Phase 1b Clinical Study and Completes $5M Second Tranche Series A Financing 04/06/10 Summary ToggleAkebia to Participate in the Future Leaders in the Biotech Industry Conference Pagination First page First Previous page Previous … Page 11 Page 12 Current page 13 Page 14 Next page Next Last page Last